Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, CollPlant Biotechnologies's average Book Value Per Share Growth Rate was -68.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -45.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -14.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of CollPlant Biotechnologies was 131.60% per year. The lowest was -45.20% per year. And the median was 2.70% per year.
During the past 13 years, the highest P/B Ratio of CollPlant Biotechnologies was 4.85. The lowest was 0.89. And the median was 2.54.
Good Sign:
CollPlant Biotechnologies Ltd stock PB Ratio (=0.99) is close to 10-year low of 0.98.
CollPlant Biotechnologies (NAS:CLGN) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
CollPlant Biotechnologies Book Value per Share Related Terms
CollPlant Biotechnologies Book Value per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CollPlant Biotechnologies Book Value per Share Chart
CLGN vs CPMV, TCRT, DRMA: Book Value per Share Comparison
For the Biotechnology subindustry, CollPlant Biotechnologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CollPlant Biotechnologies PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where CollPlant Biotechnologies's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CollPlant Biotechnologies (CLGN) has a Book Value per Share of $0.34 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on CollPlant Biotechnologies and its competitors.
Is CollPlant Biotechnologies' Book Value per Share too high?
CollPlant Biotechnologies' current Book Value per Share is $0.34. Overall, CollPlant Biotechnologies has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CollPlant Biotechnologies' Book Value per Share compare to CPMV and TCRT?
CollPlant Biotechnologies' Book Value per Share of $0.34 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on CollPlant Biotechnologies and its competitors. CollPlant Biotechnologies's current Book Value per Share is $0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CollPlant Biotechnologies stock overvalued right now?
Based on GuruFocus' analysis, CollPlant Biotechnologies (CLGN) is currently considered Fairly Valued. The stock's GF Value™ is $0.29, compared to a current price of $0.31 — trading 7.7% above its estimated fair value. The current Book Value per Share is $0.34. CollPlant Biotechnologies' overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For CollPlant Biotechnologies (CLGN), the current Book Value per Share is $0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CollPlant Biotechnologies (CLGN) Overvalued in 2026?
Based on GuruFocus' analysis, CollPlant Biotechnologies stock appears to be overvalued.
The current stock price of $0.31 is trading 7.7% above its estimated GF Value™ of $0.29.
GuruFocus considers CollPlant Biotechnologies to be Fairly Valued.
Key valuation signals for CLGN:
Book Value per Share: $0.34
GF Value™: $0.29 vs. price of $0.31 (7.7% above fair value)
No single metric tells the full story. See the CLGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
35GF Score
Get the complete analysis for CLGN
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLGN has been successfully added to your 
